Company Long-Term Loans and Borrowings: vtvtherapeutics.com (VTVT)

Public company logo of vTv Therapeutics (VTVT)

vTv Therapeutics Inc. (VTVT) is accelerating the search for anti-diabetes molecules through AI screening and automated synthesis, although human trials remain the responsibility of physicians. Talent is retained via RSU shares within an intellectual environment devoid of bureaucracy. The company's debt stands at 0.00. The business is currently focusing on scaling oral therapy for type 1 diabetes to facilitate future expansion. This price chart visualizes the dynamics of this process.

VTVT vTv Therapeutics, Inc. Company Long-Term Debts (07/04/2022 - 11/01/2026)

Summary analytical data breakdowns for vTv Therapeutics (VTVT)

- market price and analyst price targets:
Stock Price vTv Therapeutics, Inc.|VTVT - Price Target Chart
- company stock exchange capitalization indicators:
Market Value vTv Therapeutics|VTVT - Total Company Value
- book capitalization information:
Accounting Value per Share vTv Therapeutics|VTVT - Book Capitalization|Market Capitalization to Book Value Ratio vtvtherapeutics.com|VTVT - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio vTv Therapeutics Inc.|VTVT - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio vTv Therapeutics, Inc.|VTVT - Company Aggregate Debts|Debts to Book Value vTv Therapeutics|VTVT - Company Long-Term Liabilities|Amount of Current Liabilities vTv Therapeutics|Quick Ratio vtvtherapeutics.com
- earnings and multiples data:
VTVT - Net Profit
Summary company analytics:vTv Therapeutics Inc.
Brand item of vTv Therapeutics Inc

High development costs for glucokinase activators at vTv Therapeutics Inc. (VTVT) necessitate stable funding; therefore, evaluating the company's long-term debt helps determine the volume of external obligations with maturities exceeding one year. Analyzing this metric reveals the balance sheet's reliance on borrowed capital, assisting investors in weighing financial risks against the business's scientific and innovative potential when determining the fundamental value of the shares.

Competitor analysis for vTv Therapeutics Inc.

Company Long-Term Debts ascendispharma.com ASND|MDGL - Company Long-Term Debt|Company Long-Term Loans and Borrowings CORT (Corcept Therapeutics Inc.)|Rhythm Pharmaceuticals Inc (RYTM) - Company Long-Term Debt|Company Long-Term Liabilities Akero Corp|MTSR (Metsera Inc) - Company Long-Term Debts|Company Long-Term Debts moonlaketx.com|Company Long-Term Liabilities CRNX (Crinetics)|NAMS (NewAmsterdam Pharma Company) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Soleno SLNO|FOLD - Company Long-Term Liabilities|89bio, Inc. - Company Long-Term Debts|Long-Term Debt agios.com|GPCR (Structure Therapeutics Inc.) - Company Long-Term Liabilities|MDXG: Amount of Long-Term Liabilities|RZLT (Rezolute Corp) - Company Long-Term Debts|Company Long-Term Debts Lexicon Corp|Company Long-Term Debts MBX|Company Long-Term Debt ALT (altimmune.com)|Company Long-Term Debt Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. (SGMT) - Long-Term Debt|BIOA - Company Long-Term Debt|BMEA: Company Long-Term Debt|QNCX: Company Long-Term Debts|GUTS - Long-Term Debt Volume|Company Long-Term Debt Agape ATP Corp|Pluri Inc (PLUR) - Long-Term Debt Volume|Company Long-Term Debt Synlogic, Inc. (SYBX)|Company Long-Term Liabilities Lipocine Corporation LPCN|Matinas BioPharma Holdings - Company Long-Term Liabilities|Spruce Biosciences Inc. - Company Long-Term Debt|GLTO: Company Long-Term Liabilities|Carmell Corp. - Amount of Long-Term Liabilities|LUMO (Lumos Pharma Corp) - Company Long-Term Liabilities|ONVO (Organovo Corp) - Company Long-Term Debt|Company Long-Term Liabilities RDUS